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ABSTRACT Objective: Gait may be a useful biomarker that can be objectively measured with wearable
technology to classify Parkinson’s disease (PD). This study aims to: (i) comprehensively quantify a battery
of commonly utilized gait digital characteristics (spatiotemporal and signal-based), and (ii) identify the
best discriminative characteristics for the optimal classification of PD. Methods: Six partial least square
discriminant analysis (PLS-DA) models were trained on subsets of 210 characteristics measured in 142
subjects (81 people with PD, 61 controls (CL)). Results: Models accuracy ranged between 70.42-88.73%
(AUC: 78.4-94.5%) with a sensitivity of 72.84-90.12% and a specificity of 60.3-86.89%. Signal-based
digital gait characteristics independently gave 87.32% accuracy. The most influential characteristics in the
classification models were related to root mean square values, power spectral density, step velocity and
length, gait regularity and age. Conclusions: This study highlights the importance of signal-based gait
characteristics in the development of tools to help classify PD in the early stages of the disease.
INDEX TERMS Classification, Machine Learning, Digital Gait, Parkinson’s disease, Partial least square-
discriminant analysis (PLS-DA).
IMPACT STATEMENT Gait characteristics quantified with wearable devices paired with machine learning
models can be used as tool in early clinical management of Parkinson’s disease.
I. INTRODUCTION
Parkinson’s disease (PD) is the second most common neu-
rodegenerative disease after Alzheimer’s disease [1]. PD
presents a combination of motor and non-motor symptoms
that collectively can cause functional disability, loss of inde-
pendence and reduced quality of life [2]. The heterogeneity of
PD creates significant problems for accurate diagnosis, par-
ticularly in the early disease stages where symptoms may be
very subtle [3]. Diagnostic accuracy to differentiate PD from
other neurological disorders by movement disorder specialists
ranges between 74% and 80% [4]. PD state markers (status
i.e., with or without PD) with strong sensitivity and specificity
also have potential to act as trait markers (detection of dis-
ease in its prodromal stage). They are therefore of paramount
importance because they could contribute towards timely and
accurate diagnosis and clinical management [5].
Gait is a potential state and trait marker because gait im-
pairments present in very early disease [6], precede the onset
This work is licensed under a Creative Commons Attribution 4.0 License. For more information, see http://creativecommons.org/licenses/by/4.0/
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of overt motor signs and evolve more rapidly than other motor
features of PD [7]. Tools to objectively quantify discrete gait
characteristics include pressure insoles/mats, 3D motion cap-
ture, force plates, electromyography, and instrumented walk-
ways/treadmills [8]. Although they are essential to accurately
characterize gait impairments in clinical populations, their
routine use is limited to research settings due to cost and the
expertise required to use them [9], [10]. If gait assessments
are to provide state, and potentially trait markers for PD,
development of tools that are highly specific and sensitive to
PD, whilst remaining clinically and ecologically viable, are
essential.
Wearable devices such as accelerometers provide a solu-
tion to this challenge. They are capable of quantifying digi-
tal gait characteristics objectively in clinical/laboratory-based
settings as well as in real-world conditions [11]. Accelerome-
ters can capture spatiotemporal characteristics similar to other
gait analysis tools [12]. They can also capture gait contin-
uously over long distances/durations, which drastically in-
creases the opportunity to extract additional meaningful infor-
mation. For example, using signal processing techniques, time
and frequency domain analysis can quantify signal magnitude,
regularity, complexity, smoothness, and symmetry [13]–[15].
These alternative signal derived gait characteristics may pro-
vide complementary/superior state markers in early PD [16]
and in objective monitoring of PD [17]. The optimal charac-
teristic or combination therefore remains unclear.
Tools are needed to evaluate the optimal combination of
characteristics for use in PD in order to improve disease classi-
fication. Data driven modelling using machine learning (ML)
algorithms when combined with multi-dimensional gait can
be used to address this question [18]–[21]. Whilst this previ-
ous work points to the potential, it is limited to small sample
sizes, limited gait characteristics and the risk of overfitting
data due to high correlation with multiple variables derived
from the same signal [9].
Because accelerometers can provide a large amount of gait
characteristics, a comprehensive analysis on an adequately
sized population of mild to moderate PD subjects is required
to identify the optimal gait characteristics for use as state
markers in PD. This study therefore aims: (i) to comprehen-
sively quantify digital gait characteristics (spatiotemporal and
signal-based) from a single accelerometer in people with mild
to moderate PD, and (ii) to explore the best discriminative
digital gait characteristics for optimal classification of PD. We
hypothesize that a data driven approach where signal based
characteristics combined with more typical spatiotemporal
gait variables will be superior to quantify gait in PD and as
a result, would contribute a feasible and objective method to
aid the diagnosis of PD.
II. RESULTS
Table 1 shows demographics, cognitive and clinical character-
istics of the participants. Compared to Controls (CLs), people
with PD were of similar age, were shorter, weighed less and
had significantly poorer global cognition. The average PD
TABLE 1. Demographic and Clinical Characteristics
M: Male; F: Female; BMI: Body mass index; MoCA: Montreal Cognitive Assessment;
NFOG: New freezing of gait questionnaire; LEDD: Levodopa equivalent daily dose;
MDS – UPDRS III: Movement Disorder Society - Unified Parkinson’s Disease Rating
Scale Part III. In bold significant p values (p < 0.05).
TABLE 2. PLS-DA Classification Performance in PD From Different
Combinations of Accelerometer Derived Gait Characteristics (Char) and
Participant Demographic (DEM) Data
duration was 24 months from diagnosis at the time of gait
assessment.
A. CLASSIFICATION OF PD
Six partial least square – discriminant analysis (PLS-DA)
models were trained on the different sub-datasets (Table 2).
Three to five latent variables (components) in all the PLS-DA
models based on the predictive performance were enough to
explain the total variance of independent variables (standard
goodness of fit parameters (Q², R²X, and R²Y) provided in
supplementary Figure S1).
Table 2 shows the classification performance. Overall sig-
nal based characteristics gave better classification perfor-
mance (accuracy: 87.32%, sensitivity: 90.12%, specificity:
81.97%) compared to spatiotemporal characteristics alone
(accuracy: 70.42%, sensitivity: 76.54%, specificity: 62.3%).
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FIGURE 1. Receiver operating characteristics curve for each of the six
classification models.
By adding demographic (including MoCA) data to spatiotem-
poral and signal based characteristic models, the increase in
classification performance was negligible (<2%), while speci-
ficity of the models improved by 2–4%. By combining the
spatiotemporal characteristics to signal based characteristics
the accuracy and specificity of the model decreased slightly
(accuracy: 86.62%, sensitivity: 90.12%, specificity: 81.97%).
However, this increased again when the demographics were
added (accuracy: 88.73%, sensitivity: 90.12%, specificity:
86.89%) and is marginally better than the model trained on
the signal based characteristics and demographics (accuracy:
88.03%, sensitivity: 90.12%, specificity: 85.25%).
Figure 1 shows the area under the receiver operating charac-
teristic curve (AUC) for all the six models. The AUC is higher
for signal based characteristics as compared to spatiotemporal
gait characteristics. The addition of demographics had negli-
gible impact on models AUC.
B. IMPORTANT CHARACTERISTICS IN THE MODEL
Figure 2 shows the characteristics with a Variable Importance
in the Projection (VIP) [22] value of > = 1.5 in at least one of
the PLS-DA model components trained on the overall data set.
The VIP score for all variables (Table S1) and their definitions
(Table S3) are provided in the supplementary material.
Characteristics are ranked based on the average VIP score
of all the components in the model (Figure 2). Signal mag-
nitude based measures such as root mean square (RMS) in
all three directions (vertical (VT), mediolateral (ML) and
anteroposterior (AP)) for each pass of straight walking, per
stride and step were highly influential. Signal frequency
domain measures such as the power spectral density (PSD)
amplitude and slope of the signal in ML, harmonic ratio in
AP & VT, index of harmonicity in ML, range of signal in
AP and stride harmonic ratio in the ML & AP direction were
important. Among signal regularity based characteristics, step
and stride regularity in the ML direction were important. Spa-
tiotemporal measures such as step velocity, step length, and
step length variability were influential. Complexity of the sig-
nal, in the form of phase plot characteristic long half orbit area
asymmetry and Lyapunov exponent derived from combined
resultant axes from tri-axial accelerometer, were relevant. In
this model, the age of the subjects was also important in the
classification process.
C. STATISTICAL SIGNIFICANCE OF IMPORTANT
CHARACTERISTICS BETWEEN PD AND CL
On average, PD and CL groups walked 5 and 6 passes on the
mat respectively, with an average of 42 steps for PD and 45
steps for CL. Compared to the CL group, PD had significantly
lower signal magnitudes, signal frequency characteristics, reg-
ularity, complexity, step velocity and step length (Figure 3).
In addition, PD had higher coefficient of variability in step
length, Lyapunov exponent and signal index of harmonicity in
PSD. The mean ± standard deviation of all 210 gait character-
istics are available in the supplementary material (Table S2).
Correlation analysis results between the gait characteristics
are given in the supplementary material (Figure S2).
III. DISCUSSION
To the best of our knowledge, this is the most comprehensive
study to quantify digital gait characteristics from a single tri-
axial accelerometer and identify discriminative characteristics
for optimal classification of early stages of PD. Two hundred
and ten digital gait characteristics from spatiotemporal, sig-
nal magnitude, regularity, complexity and frequency domains
were used in this study. A PLS-DA method, which can deal
with multi-collinearity [22], [23], was used in the classifi-
cation step. Based on the results, signal based characteris-
tics (Acceleration RMS, PSD (amplitude, slope and range),
harmonic ratio, index of harmonicity and regularity) added
greater classification value compared to traditional spatiotem-
poral gait characteristics. This highlights the importance of
extracting signal based digital characteristics to support the
development of sensitive and objective pre-screening diagnos-
tic tools, to support early identification of PD.
The variety of methodologies and data analysis techniques
used across studies makes comparisons problematic due to
inconsistent findings and variable classification accuracy [20],
[24], [25]. Relative to past studies, the results here and the
methodology used, show comparable or improved accuracy
and better balance in sensitivity and specificity to classify
people with PD. Assuming that the participants in this study
are accurately diagnosed, the accuracy reported in this study
is higher than that reported by movement disorder special-
ists [4]. These results were derived from pre-extracted signal
based characteristics, tailored to assess multifaceted move-
ment patterns required to quantify the synergistic movements
seen in PD [14]. Deep learning methods such as convolutional
neural networks (CNN), could be used for larger sample sizes
VOLUME 1, 2020 67
REHMAN ET AL.: ACCELEROMETRY-BASED DIGITAL GAIT CHARACTERISTICS FOR CLASSIFICATION OF PARKINSON’S DISEASE: WHAT COUNTS?
FIGURE 2. The importance of variables in the projection of the components (comp) on overall dataset. The further the line from 0 the more important
the variable.
to find the better classification accuracy from raw accelera-
tion signals [18]. Potentially, these approaches could achieve
favorable results from bigger datasets; however, the high accu-
racy reported in this study, combined with the ability to deter-
mine the key characteristics that contributed to it, is favorable
from a clinical perspective. A lot of data driven approaches
are based on a “black box” approach which may be difficult
to fully understand and interpret. The adopted approach here
provides interpretable information to describe how PD gait
differs from older adult controls, therefore, unlike a black box
method, it can provide targets for intervention.
The key characteristics that achieved VIP scores greater
than 1.5 included a variety of traditionally adopted spatiotem-
poral information and acceleration signal-based characteris-
tics. Spatiotemporal characteristics replicating variables from
instrumented walkways have been predominantly assessed
due to the advantage of increased interpretability [12], [26].
Due to their discrete nature, a drawback of these charac-
teristics is that they solely quantify movements of the feet
in the line of progression. For complex measures such as
asymmetry and variability, which are highly prevalent in PD
[26]–[28] even at the early stages [6], we argue that these
gait characteristics are best quantified using information from
multiple planes of motion [29], [30]. Here, the top five per-
forming characteristics were from mediolateral signals, which
due to being quantified at L5, are related to measures of
stability/postural control during gait [31], [32]. We propose
the additional information achieved through a comprehensive
analysis of each component of the signal can better quan-
tify these complex characteristics and is the reason for an
improved classification accuracy. Previously when examining
people with PD with the use of instrumented walkways, step
width and its variability showed low correlation with other
gait characteristics but was highly relevant for classification
[33], [34]. To our knowledge, single accelerometers located
on the lower back, cannot accurately quantify step width and
the benefit of assessing it with the already included charac-
teristics is unknown. Future research should aim to include
68 VOLUME 1, 2020
FIGURE 3. Statistical difference between people with PD (PD) and CL, characteristics are standardized into z-score, deviation from zero along the axis
radiating from the center of the plot represents how many standard deviations the PD differ from CL (range: ±1 SD, z-score based on CL means and SDs),
and star indicates p < 0.05.
step width, or equivalent proxy characteristics, so that it can
contribute to an expected higher classification accuracy.
A. LIMITATIONS AND FUTURE WORK
The PLS-DA model was trained and tested on a mild to
moderate PD cohort, who had gait assessment within an av-
erage of 24 months from clinical diagnosis. We considered
them at an early stage of PD and assumed that the partici-
pants were accurately diagnosed; all participants met the UK
Brain Bank criteria for PD at the time of assessment. They
therefore may not be generalizable to an older/younger group
with greater/smaller disease severity and disease duration.
All participants were on dopaminergic medication; although
this reflects clinical practice, future studies should consider
replicating these methods in a drug naïve cohort. Although
it is presumed that state variables are good targets for the
identification of trait markers, it is possible that findings from
this study may not be generalizable for prodromal PD. A
trained model should be tested on a diverse prodromal co-
hort followed longitudinally with diagnosis confirmed post
mortem.
We used five domains to try to map the presented features,
future work should also consider factor analysis approaches to
determine gait models that includes independent domains to
group gait variables [13]. Furthermore, future efforts should
test if these variables are not only sensitive, but also spe-
cific to detect PD gait impairment, and should determine
the generalizability of the results to other neurodegenerative
diseases that present similar mobility impairment. Although
accelerometers are proposed as a feasible tool, they are not
currently adopted as part of PD diagnostics and substantial
efforts are required to overcome the challenges preventing
their potential adoption [35]. Wearable sensors are becoming
smaller and combining multiple sensors in a single low price
device is now possible [36]. It is plausible that at the time
of potential clinical adoption, sensors such as gyroscopes and
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magnetometers could contribute towards a more accurate cal-
culation of existing, or provide additional, movement based
characteristics, such as turning quality. These characteristics
may contribute to an improved classification accuracy. Re-
search into their inclusion is therefore warranted. Gyroscopes
would also improve the ability to detect straight line walking
episodes in free living environments. This would allow us
to assess gait within the participant’s natural environment.
Future work might focus on the replication of the analyses
based on free living data.
B. APPLICATIONS/CLINICAL IMPLICATIONS
The objective nature of gait assessment with a wearable sen-
sor, together with the practical advantages of its implementa-
tion to a clinical environment motivates its adoption. If this
adoption becomes a reality, the comprehensive approach pre-
sented here performed better in terms of trade-off between
sensitivity and specificity than previously proposed models
and is built using clinically interpretable characteristics quan-
tified with an accelerometer. The results from the current
methodology provide evidence for a favorable approach to
identify early movement diagnostic markers of PD. This im-
proved accuracy is potentially a step in the right direction to-
wards an approach that can aid predictions of specific disease
progression and an understanding of the underlying mecha-
nisms that underpin gait impairment in PD.
IV. CONCLUSIONS
This study showed that a comprehensive approach that com-
bined signal based characteristics with traditional measures
of gait and participant demographic information, was optimal
for the classification of the PD group. The results therefore
show that, if using wearable sensors to provide potential state
markers of PD, characteristics taken from the multiple signal
based domains and planes of motion better highlight synergis-
tic movements of people with PD. Additionally out of the 210
that were included, it highlighted which gait characteristics
were the most capable to highlight these synergistic move-
ments. It is hoped these results are a step towards the adoption
of comprehensive approaches in future attempts to find the
best movement based state markers at the early stages of PD.
These approaches may be applicable for better classification
at the prodromal stage or even between phenotypes where gait
could be considered as a digital biomarker for PD.
V. MATERIALS AND METHODS
A. PARTICIPANTS
Data from 81 people with PD and 61 CLs, collected as part of
the “Incidence of Cognitive Impairment in Cohorts with Lon-
gitudinal Evaluation - GAIT” (ICICLE-GAIT) study, were
used in this work [37]. The study was approved by the “New-
castle and North Tyneside research ethics committee” (REC
No. 09/H0906/82). All the participants gave their written in-
formed consent before participating in the study.
B. DEMOGRAPHICS AND CLINICAL MEASURES
Demographic characteristics such as age, height and weight
were recorded for all the subjects. Cognition was assessed
with the Montreal Cognitive Assessment (MOCA) [38].
Freezing in gait was assessed with New Freezing of Gait
(NFOG) questionnaire [39]. Levodopa equivalent daily dose
(LEDD mg/day) was calculated according to defined criteria
[40]. To assess PD motor severity, Hoehn & Yahr stage [41]
and the Movement Disorder Society Unified Parkinson’s Dis-
ease Rating Scale [42] (MDS-UPDRS) – Part III were used.
C. EQUIPMENT
Participants wore a tri-axial accelerometer (Axivity AX3, di-
mensions: 23.0 × 32.5 × 7.6 mm, Sample frequency 100 Hz,
Range: ± 8g), on the lower back (L5), affixed by double
sided tape (BSN Medical Limited, Hull, U.K) [12]. An in-
strumented mat (Platinum model GAITRite: 7.0 × 0.6 m,
Spatial accuracy: 1.27 cm, Temporal accuracy of 1 sample
(240 Hz, ∼ 4.17 ms)) was used for accurate segmentation and
identification of walking.
D. TESTING PROTOCOLS AND DATA SEGMENTATION
PD participants were assessed one hour after dopaminer-
gic medication intake. Participants walked at their preferred
walking speed for two minutes continuously over a 25 m
oval circuit (Figure 4-(a)). Axivity was synchronized with the
real-time clock of GAITRite. Straight walks with each pass
on mat, strides, and steps were automatically segmented in
Matlab based on the heel strike and toe-off timings from the
GAITRite mat (Figure 4-(b)).
E. GAIT CHARACTERISTICS EXTRACTION
Along with spatiotemporal characteristics, various signal-
based gait characteristics were extracted (defined in the sup-
plementary material (Table S3)). Depending on the character-
istic, segmentation of data on a step-by-step, stride-by-stride
or multiple consecutive strides basis was required. Two hun-
dred and ten gait characteristics (spatiotemporal and signal-
based) were extracted and divided into five different domains
(spatiotemporal, frequency based, signal magnitude, signal
regularity, and signal complexity) as shown in Figure 4-(c).
In the spatiotemporal domain (N: 25 characteristics), 14
gait characteristics were extracted based on previous work
[12]. Cadence, and the coefficient of variability for both step
and strides characteristics was added. In the signal power
spectral density domain we extracted frequency based charac-
teristics (N: 56) including amplitude, width, slope, and range
of the dominant peak from the power spectral density [43],
harmonic ratio [44], and index of harmonicity [45]. In the sig-
nal regularity domain (N: 20), various outputs from deriving
the step and stride regularity from performing autocorrelation
and also, the gait symmetry index were quantified [46], [47].
From the signal magnitude domain (N: 84), root mean square,
jerk, jerk ratio, maximum and minimum values were extracted
for each step, stride, and straight walk from each axis of the
70 VOLUME 1, 2020
FIGURE 4. Process flow for quantification of gait characteristics: (a) Gait assessment in the lab, (b) Accelerometery signal segmentation based on
GAITRite timing for each pass, stride and step, (c) Extraction of gait characteristics
VOLUME 1, 2020 71
REHMAN ET AL.: ACCELEROMETRY-BASED DIGITAL GAIT CHARACTERISTICS FOR CLASSIFICATION OF PARKINSON’S DISEASE: WHAT COUNTS?
signal [14]. In the complexity domain (N: 25), we included
geometrical characteristics extracted based on the shapes in
the phase plots [48] along with Lyapunov exponents [49].
F. CLASSIFICATION MODELING AND VARIABLE
IMPORTANCE
Partial Least Square (PLS) regression [50] combined with
discriminant analysis (PLS-DA) [23] was used to handle 216
independent characteristics (including gait, demographics and
clinical information) to classify two dependent variables (peo-
ple with PD & CL) from a relatively low number of subjects
(N = 142). The motivation to use this method and details
about it are given in the supplementary material S1. A separate
model for each selection of independent characteristics was
built for classification of PD. The number of components
for the model was determined on the cross-validation per-
formance in PLS-DA. The quality of each predictive model
based on the number of components, was determined by the
cumulated index Q², which assesses global fitness (predictive
accuracy). Its value should be greater than 0, with values close
to 1 being ideal for identifying the most relevant components
in the model. Similarly, to determine the explanatory power of
the components for the independent and dependent variables,
cumulative index of R²X and R²Y were used respectively to
determine the quality of the model. Ideally, these indexes
should be greater than 0 and close to 1 for each component to
be included in the model. The importance of each independent
variable in the model was determined based on the projection
(VIP) score, which shows the importance of the explanatory
variables for building the model components [22]. The VIP
score was used to identify the variables that were moderately
(0.8 < VIP < 1) or highly influential (VIP > 1) in the model
[22]. Independent t-tests were performed on these identified
variables to evaluate the difference between people with PD
and CL. Pearson’s correlation analysis was also performed to
check dependency among the important gait characteristics.
SUPPLEMENTARY MATERIALS
S1: Motivation to use PLS-DA and method detail. Figure S1:
PLS-DA models quality based on the number of components.
Table S1: Variable importance in the projection of the compo-
nents in PLS-DA. Table S2: Difference between people with
PD and CL based on independent sample t-test. Table S3:
Definition of gait characteristics used in the study.
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